Supportive: treat the cause; assess volume status; stop NSAIDs, ACE inhibitors, angiotensin receptor blockers, diuretics, metformin (if eGFR is below 30) and other nephrotoxins; monitor urine output with a catheter in the sick; hourly vital signs.
Pharmacological
- Hypovolaemia: crystalloid (Ringer lactate or 0.9 percent sodium chloride) 500 mL over 15 to 30 minutes, reassess, repeat to a mean arterial pressure above 65 mmHg and urine output above 0.5 mL/kg/h (250 mL boluses in heart failure or elderly); avoid more than 30 mL/kg without reassessment; avoid hydroxyethyl starch.
- Haemorrhage: red cell transfusion (haemoglobin below 7 g/dL), control the source.
- Septic shock: antibiotics within the first hour and noradrenaline 0.05 to 0.5 microgram/kg/min to keep mean arterial pressure above 65 mmHg.
- Cirrhosis with hepatorenal syndrome: stop diuretics, albumin 1 g/kg (maximum 100 g) on day 1 then 20 to 40 g daily with terlipressin 0.85 mg IV every 6 hours (increase to 1.7 mg every 6 hours after 3 days if creatinine has not fallen by 30 percent) or noradrenaline infusion.
- Heart failure: diuretics (furosemide 40 to 80 mg IV), inotropes (dobutamine 2.5 to 10 microgram/kg/min) in low output state.
- Hyperkalaemia: calcium gluconate 10 percent 10 mL IV, insulin 10 units with 25 g glucose, salbutamol 10 to 20 mg nebulised, and bicarbonate if acidotic.
- Diarrhoea: oral rehydration solution 50 to 100 mL/kg over 4 hours.
Procedures: renal replacement therapy for refractory hyperkalaemia, acidosis, pulmonary oedema or uraemic complications; angioplasty or revascularisation for bilateral renal artery stenosis in selected cases.
Special groups: elderly (avoid over-treatment with fluids), pregnancy (hyperemesis, pre-eclampsia, haemorrhage), children (gastroenteritis; calculate fluids by weight), patients on diuretics (restart cautiously).
Red flags: shock, oliguria for more than 12 hours despite fluids, potassium above 6.5 mmol/L, pH below 7.2, fluid overload.
Follow-up: creatinine daily until it falls then at 7 days and 3 months; restart ACE inhibitors cautiously once stable; review at 3 months for chronic kidney disease.